 Home > Medical News > Latest Medical News > Pfizer's Oral Covid-19 Drug Paxlovid Receives FDA Emergency Use Authorization

Pfizer's Oral Covid-19 Drug Paxlovid Receives FDA Emergency Use Authorization

 Last Update: 2022-02-24
 Source: Internet
 Author: User

Tags

federal food drug administration

foxy drug

hazardous drug list

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 22, Pfizer announced that the U.

Paxlovid is a compound preparation of 3CL protease inhibitor nirmatrelvir and low-dose Ritonavir (Ritonavir), which is administered by 300mg (two 150mg tablets) of nirmatrelvir and one 100mg tablet of ritonavir for oral administration by new crown patients, Administer 2 times a day for 5 days

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.